Wells Fargo’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$168 Sell
2025
Q1
$14.4K Buy
2024
Q4
$41.7K Buy
2024
Q3
$38K Buy
2024
Q2
$30.1K Buy
2024
Q1
$30.7K Buy
2023
Q4
$13.2K Buy
2023
Q3
$20.7K Sell
2023
Q2
$42.8K Buy
2023
Q1
$20.2K Buy